Inventor · disambiguated record
Sampath-Kumar Anandan
Also filed as: ANANDAN SAMPATH K · ANANDAN SAMPATH-KUMAR
18 granted patents·20 pending applications·131 citations·filing 2003–2025
93Inventor score
Files withARETE THERAPEUTICS INC9INIPHARM INC9MAYO FOUND MEDICAL EDUCATION & RES5VICURON PHARM INC4PROTAGONIST THERAPEUTICS INC3
Top patents by PatentIndex Score
38 records- 0195US10729676B2Opioid agonist peptides and uses thereofPROTAGONIST THERAPEUTICS INC·Filed 2019·Granted Aug 4, 2020·10 cites·18 claims
- 0294US10278957B2Opioid agonist peptides and uses thereofPROTAGONIST THERAPEUTICS INC·Filed 2018·Granted May 7, 2019·16 cites·19 claims
- 0391US10407468B2Methods for synthesizing α4β7 peptide antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2017·Granted Sep 10, 2019·13 cites·24 claims
- 0490US11339126B2Compounds for the reducing lipotoxic damageMAYO FOUND MEDICAL EDUCATION & RES·Filed 2018·Granted May 24, 2022·3 cites·15 claims
- 0590US7772245B2Inhibitors of histone deacetylaseMIIKANA THERAPEUTICS INC·Filed 2006·Granted Aug 10, 2010·10 cites·8 claims
- 0690US7345043B2Inhibitors of histone deacetylaseMIIKANA THERAPEUTICS·Filed 2005·Granted Mar 18, 2008·27 cites·19 claims
- 0788US7361743B2Lincomycin derivatives possessing antibacterial activityPFIZER·Filed 2005·Granted Apr 22, 2008·12 cites·25 claims
- 0885US12325690B2Compounds for the reducing lipotoxic damageMAYO FOUND MEDICAL EDUCATION & RES·Filed 2024·Granted Jun 10, 2025·0 cites·11 claims
- 0984US11827619B2Dichlorophenol HSD17B13 inhibitors and uses thereofINIPHARM INC·Filed 2023·Granted Nov 28, 2023·1 cites·28 claims
- 1084US9814739B22′-ethynyl nucleoside derivatives for treatment of viral infectionsNOVARTIS AG·Filed 2016·Granted Nov 14, 2017·2 cites·10 claims
- 1182US11976040B2Compounds for the reducing lipotoxic damageMAYO FOUND MEDICAL EDUCATION & RES·Filed 2023·Granted May 7, 2024·0 cites·21 claims
- 1280US7199106B2Lincomycin derivatives possessing antimicrobial activityVICURON PHARM INC·Filed 2004·Granted Apr 3, 2007·11 cites·29 claims
- 1380US2025340512A1Compounds for the reducing lipotoxic damageMAYO FOUND MEDICAL EDUCATION & RES·Filed 2025·Application pending·0 cites
- 1478US11623915B2Compounds for the reducing lipotoxic damageMAYO FOUND MEDICAL EDUCATION & RES·Filed 2022·Granted Apr 11, 2023·0 cites·11 claims
- 1577US7199105B2Lincomycin derivatives possessing antibacterial activityVICURON PHARM INC·Filed 2004·Granted Apr 3, 2007·8 cites·29 claims
- 1677US7164011B2Lincomycin derivatives possessing antibacterial activityVICURON PHARM INC·Filed 2003·Granted Jan 16, 2007·8 cites·29 claims
- 1776US7256177B2Lincomycin derivatives possessing antibacterial activityVICURON PHARM INC·Filed 2004·Granted Aug 14, 2007·8 cites·88 claims
- 1875US9556216B22′-Ethynyl nucleoside derivatives for treatment of viral infectionsANANDAN SAMPATH-KUMAR·Filed 2013·Granted Jan 31, 2017·2 cites·15 claims
- 1971US12227489B2Dichlorophenol HSD17B13 inhibitors and uses thereofINIPHARM INC·Filed 2023·Granted Feb 18, 2025·0 cites·28 claims
- 2060US2025376457A1Dichlorophenol hsd17b13 inhibitors and uses thereofINIPHARM INC·Filed 2025·Application pending·0 cites
- 2158US2008139535A1Inhibitors of histone deacetylaseMIIKANA THERAPEUTICS·Filed 2008·Application pending·0 cites
- 2255US2025320186A1Hsd17b13 inhibitors and uses thereofINIPHARM INC·Filed 2023·Application pending·0 cites
- 2354US2005197336A1Inhibitors of histone deacetylaseMIIKANA THERAPEUTICS CORP·Filed 2004·Application pending·0 cites
- 2454US2025100993A12-substituted thiazole hsd17b13 inhibitors and uses thereofINIPHARM INC·Filed 2023·Application pending·0 cites
- 2551US2009270382A1Soluble epoxide hydrolase inhibitorsARETE THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 2650US2024208929A1Hydroxypyridine hsd17b13 inhibitors and uses thereofINIPHARM INC·Filed 2022·Application pending·0 cites
- 2750US2024208959A1Thiazole/isothiazole hsd17b13 inhibitors and uses thereofINIPHARM INC·Filed 2022·Application pending·0 cites
- 2850US2009082350A1Soluble epoxide hydrolase inhibitorsARETE THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 2950US2005250784A1Inhibitors of histone deacetylaseMIIKANA THERAPEUTICS CORP·Filed 2005·Application pending·0 cites
- 3050US2009082423A1Soluble epoxide hydrolase inhibitorsARETE THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 3149US2009023731A1Soluble epoxide hydrolase inhibitorsARETE THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 3247US2008200444A1Soluble epoxide hydrolase inhibitorsARETE THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 3347US2008221100A1Soluble epoxide hydrolase inhibitorsARETE THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 3447US2008227780A1Soluble epoxide hydrolase inhibitorsARETE THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 3547US2023286923A1Quinazolinone hsd17b13 inhibitors and uses thereofINIPHARM INC·Filed 2021·Application pending·0 cites
- 3647US2023278978A1Thiophene hsd17b13 inhibitors and uses thereofINIPHARM INC·Filed 2021·Application pending·0 cites
- 3746US2009247521A1Soluble epoxide hydrolase inhibitors for the treatment of endothelial dysfunctionARETE THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 3843US2008200467A1Soluble epoxide hydrolase inhibitorsARETE THERAPEUTICS INC·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sampath-Kumar Anandan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →